MEDINCELL

What this means for you

Registered since 16 Jun 2020. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

88404359

Registration number

6077767

Mark type

Stylized text

Filed

26 Apr 2019

Published for opposition

31 Mar 2020

Registered

16 Jun 2020

Attorney of record

Stephen P. McNamara

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; pharmaceutical preparations, namely, a drug delivery system comprising pharmaceutical compositions for subcutaneous or intraarticular administration for the continuous release of therapeutic agents for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; veterinary preparations and substances for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; veterinary preparations, namely, a drug delivery system comprising compositions that facilitate continuous release delivery of a wide variety of therapeutic subcutaneous or intraarticular veterinary agents; pharmaceutical compositions for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceutical and veterinary pharmaceutical preparations; Drug delivery agents in the form of compounds that facilitate controlled release delivery of subcutaneous or intraarticular active ingredients for a wide variety of pharmaceuticals and veterinary pharmaceutical preparations; Drug delivery agents in the form of drug delivery compounds that facilitate sustained or extended release of the active ingredients for a wide variety of pharmaceuticals and veterinary pharmaceutical preparations; Drug delivery agents in the form of compounds that facilitate delivery of injectable pharmaceutical and veterinary pharmaceutical preparations; sustained or extended release drug delivery agents being compounds used to facilitate delivery of drugs, sold as an integral component of pharmaceutical and veterinary pharmaceutical preparations for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; chemical preparations for medical or pharmaceutical use for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; Carriers and mediums being drug delivery agents comprised of compounds for facilitating the delivery of pharmaceutical and veterinary pharmaceutical preparations for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; pharmaceutical and veterinary pharmaceutical preparations and substances for subcutaneous delivery for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders

Owner

• MedinCell S.A., Jacou, FR
• MedinCell S.A., Jacou, FR
• MedinCell S.A., Jacou, FR

Prosecution history

• 16 Jun 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
• 16 Jun 2020 — REGISTERED-PRINCIPAL REGISTER
• 31 Mar 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 31 Mar 2020 — PUBLISHED FOR OPPOSITION
• 11 Mar 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 27 Feb 2020 — ELECTRONIC RECORD REVIEW COMPLETE
• 07 Feb 2020 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
• 31 Jan 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 31 Jan 2020 — EXAMINER'S AMENDMENT ENTERED
• 31 Jan 2020 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
• 31 Jan 2020 — EXAMINERS AMENDMENT E-MAILED
• 31 Jan 2020 — EXAMINERS AMENDMENT -WRITTEN
• 09 Jan 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 08 Jan 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 08 Jan 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED